ENTITY
Cathay Biotech

Cathay Biotech (688065 CH)

39
Analysis
MaterialsChina
Cathay Biotech Inc. engages in synthetic biology, producing new materials on an industrial scale through bio-manufacturing. The Company focuses on polyamide industry's value chain covering biological long-chain dibasic acid, bio-based pentane diamine, bio-based polyamide, and more. Cathay Biotech markets its products worldwide.
more
28 Jan 2024 05:30

Index Rebalance & ETF Flow Recap: CSI300, CSI500, SSE50, ChiNext, KOSPI200, Renesas, IDX30/LQ45

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
681 Views
Share
bullishKunlun Tech
23 Jan 2024 06:20

CSI500 Index Rebalance Preview: High Turnover & Big Flow

We forecast 50 changes in June leading to one-way turnover of 9.1% and one-way trade of CNY 5.34bn. There will be over 1x ADV to trade on 28...

Logo
657 Views
Share
22 Jan 2024 06:10

CSI300 Index Rebalance Preview: A Dozen Changes for June

We forecast 12 changes for the CSI300 Index in June with a one-way turnover of 1.3% and one-way trade of US$703m. The potential adds have...

Logo
716 Views
Share
06 Dec 2023 11:40

Quiddity Aggregation of CSI300/500 and SSE50/180 Index Flows for Dec 2023: US$4.2bn One-Way!

Large Mainland China index flows coming up. I expect the CSI300/500 and the SSE50/180 Inclusion and Exclusion events to take place at the close of...

Share
26 Nov 2023 11:00

CSI300 Index Rebalance: 14 Changes & A Few Surprises

There are 14 changes for the CSI300 in December. Most of the changes were expected and there are a few surprises as the index committee has...

Logo
1.2k Views
Share
x